Humanoid Global Announces Commitment to a Strategic Investment in Agility Robotics, Developers of One of the World’s First Commercially Deployed Humanoid Robot
Globenewswire· 2025-09-16 19:30
– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Vancouver, BC & Salem, Oregon, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that it has committed to an indirect strategic investment of US$ 145,000 into Agil ...
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
Globenewswire· 2025-09-16 19:30
MALVERN, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced the publication of a new article in a peer-reviewed journal Biomolecules, which describes the pharmacokinetic (PK) profile of a new crystal form of buntanetap and compares it to the old form across several studie ...
Beneficient Granted Listing Extension by Nasdaq
Globenewswire· 2025-09-16 19:30
DALLAS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated September 9, 2025, the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) had granted the Company’s request for contin ...
Phillips Edison & Company to Host PECO GROW Update for Financial Advisors and Retail Investors on September 24
Globenewswire· 2025-09-16 19:30
CINCINNATI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, will host a PECO GROW Update for financial advisors and retail investors on Wednesday, September 24, 2025, at 12:00 p.m. ET. During the webcast, PECO will discuss the business and answer questions from financial advisors and retail investors. Chairman and Chief Executive Offic ...
Strive Announces Acquisition of MSTR True North Inc. Appoints Jeff Walton as Chief Risk Officer & CEO of True North
Globenewswire· 2025-09-16 19:15
Dallas, TX, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. announces a strategic acquisition of MSTR True North Inc. (True North) in a de minimis cash transaction. True North is cash flow positive and the transaction synergies are expected to allow enhanced platform expansion without additional cost. This move cements Strive’s position at the forefront of Bitcoin advocacy in the new frontier of Digital Capital and Digital Credit. As part of the acquisition, Strive has appointed True North founder Jeff Walt ...
Draganfly and Autonome to Highlight Landmine Route Clearance Technology at Countering Explosives Conference
Globenewswire· 2025-09-16 19:15
DPRO AUTONOME MAGIC PAYLOAD Tampa, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, announced it will attend the upcoming Countering Explosives Conference hosted by Defence iQ. Together with Autonome Labs, Draganfly will highlight progress on the M.A.G.I.C (Mine and Ground Integrated Clearance) system, integrated on Draganfly’s Heavy Lift UAV, which is de ...
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
Globenewswire· 2025-09-16 19:03
First patient in South Korea dosedMIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor today announced activation of two South Korean clinical trial sites participating in its Phase 1/1b open label study to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of PAS-004, in adult participants with neurofibromatosis t ...
OMS Energy Technologies(OMSE.US) CEO How Meng Hock彭博專訪——能源轉型背景下的增長與全球佈局
Globenewswire· 2025-09-16 19:00
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- 2025年,全球能源市場正在經歷轉型與變革。在此背景下,總部位於新加坡的 OMS能源技術公司(OMSE.US)首席執行官 How Meng Hock 近日做客彭博電視訪談節目,回顧公司五十餘年的發展歷程,並就於美國納斯達克成功上市、全球能源格局及未來戰略佈局發表了深入見解。 OMSE成立於1972年,深耕上游石油與天然氣領域,主要為鑽井和生產環節提供工程化產品和服務,涵蓋地面井口與聖誕樹、OCTG(油管、套管及鑽杆)以及完井設備,同時為行業提供維護與技術支持。經過多年發展,公司在東南亞已建立11個運營設施,並於2022年在沙烏地阿拉伯啟用了迄今為止最大、最先進的生產基地。目前,公司全球僱員總數約600人,全球客戶200+,業務範圍覆蓋東南亞和中東,穩步邁向國際化,並憑藉ISO 9001、API Q1等權威認證及穩健財務表現,成為全球能源行業信賴的合作夥伴。 在談及2025年公司成功登陸美國資本市場時,How Meng Hock強調,這一步並非單純為了融資,而是著眼於品牌建設和全球擴張的長遠目標。2025年8月28日——O ...
Updated Studies Confirm Barrick’s Fourmile as One of This Century’s Most Significant Gold Finds
Globenewswire· 2025-09-16 19:00
COLORADO SPRINGS, Colo., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) – The Fourmile project in Nevada is cementing its position as one of the century’s greatest gold discoveries, updated studies by 100%-owner Barrick show. Backed by ongoing 2025 evaluation results1 and the 2024 mineral resource, the new preliminary economic assessment (PEA) underscores Fourmile’s rare combination of grade, scale and exploration upside, confirming its potential to become one of the world’s ...
Green Thumb Industries Announces $50 Million Share Repurchase Program
Globenewswire· 2025-09-16 19:00
CHICAGO and VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, announced that its board of directors authorized a $50 million share repurchase program. The repurchase program authorizes, pursuant to a normal course issuer bid, the repurchase of up to 10,364,640 of its subordinate voting shares (“shares”) from time to ...